DANA Inc: Form 10-Q for the period ended Mar 31, 2025
Filed with the SEC on Apr 30, 2025 and accepted by EDGAR at Apr 30, 2025, 12:05 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-01-01 to 2025-03-31 | $2.35bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2025-01-01 to 2025-03-31 | $2.13bn | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2025-01-01 to 2025-03-31 | $132.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2025-01-01 to 2025-03-31 | $72.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2025-01-01 to 2025-03-31 | $39.0m | us-gaap:InterestExpense |
| Income tax | 3 months2025-01-01 to 2025-03-31 | $8.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-01-01 to 2025-03-31 | $25.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-01-01 to 2025-03-31 | $0.17 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-01-01 to 2025-03-31 | $0.17 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-01-01 to 2025-03-31 | 147,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2025-01-01 to 2025-03-31 | −$37.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2025-01-01 to 2025-03-31 | $75.0m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 3 months2025-01-01 to 2025-03-31 | $15.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2025-03-31 | $507.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-03-31 | $4.03bn | us-gaap:AssetsCurrent |
| Total assets | At period end2025-03-31 | $7.80bn | us-gaap:Assets |
| Current liabilities | At period end2025-03-31 | $2.83bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-03-31 | $6.17bn | us-gaap:Liabilities |
| Short-term borrowings | At period end2025-03-31 | $130.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2025-03-31 | $1.38bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-25-013716. Last ingested by Listed: Oct 29, 2026, 04:34 ET. Listed shows no prices and gives no investment advice.